Remicade 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9KZ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,593
Award facts
- Contract value 100% obligated
- $24,592.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $24,592.90, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for the supply of Remicade 100 mg vials. The contract was awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The Defense Logistics Agency, which serves as the funding federal agency, issued this non-set-aside competitive award as a delivery order under an existing contract vehicle.
This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. This comprehensive IDC enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and critical medical commodities. Remicade, a TNF-alpha inhibitor used primarily in treating autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease, represents one of the specialized pharmaceutical products delivered through this strategic vehicle to support the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9KZ9?
SPE2DR26F9KZ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9KZ9 worth?
The government has obligated $24,593 on SPE2DR26F9KZ9.
Is contract SPE2DR26F9KZ9 an order under another contract?
Yes. SPE2DR26F9KZ9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KZ9 competed?
The extent of competition for SPE2DR26F9KZ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award